Skip to content
Home
About
Overview
Meet the Team
PrimeVigilance
CRO
Overview
Orphan Drug Development
Therapeutic Expertise
Clinical Expertise: Phase I–IV
Site Support Services
COVID-19
CRO Publications and Resources
Investors
Investor Relations
Reports and Presentations
Shareholder Communications
News and Events
Overview
Regulatory News
Careers
Contact
Legal Information
Privacy & Cookie Policies
Sitemap
News and Events
Learn more about current happenings at Ergomed.
Latest News
1 Feb 2017
Ergomed notes co-development partner Aeterna Zentaris Completes Zoptrex™ Pivotal Phase [...]
17 Jan 2017
Ergomed to report very strong 2016 revenue growth and order [...]
20 Dec 2016
Proposed Board changes
30 Nov 2016
Award of options by Chief Executive Officer over personally owned [...]
29 Nov 2016
Ergomed strengthens PrimeVigilance with acquisition of European pharmacovigilance and regulatory [...]
16 Nov 2016
Ergomed’s co-development partner Modus Therapeutics announces that the Independent Data [...]
«
1
2
…
18
19
20
…
28
29
»
Previous Events
17 Nov 2020
Ergomed presenting at Jefferies Virtual London 2020 Healthcare Conference